There are 2934 resources available
1831 - First in human, a phase I study of ISU104, a novel ErbB3 monoclonal antibody, in patients with advanced solid tumors
Presenter: Sung-Bae Kim
Session: Poster Discussion – Developmental therapeutics
Resources:
Abstract
2878 - First-in-human, first-in-class phase I study of MTL-CEBPA, a RNA oligonucleotide targeting the myeloid cell master regulator C/EBP-_, in patients with advanced hepatocellular cancer (HCC)
Presenter: Debashis Sarker
Session: Poster Discussion – Developmental therapeutics
Resources:
Abstract
Addressing optimal firstline therapy options in luminal ABC (endocrine alone vs. endocrine + targeted vs. chemotherapy)
Presenter: Fatima Cardoso
Session: Challenges in the management of luminal ER + MBC
Resources:
Slides
Webcast
Management options after progression on CDK 4/6 inhibitors
Presenter: Fabrice André
Session: Challenges in the management of luminal ER + MBC
Resources:
Slides
Webcast
Molecular profiling of pancreatic cancer in guiding tumour biology understanding and drug target discovery
Presenter: David Tuveson
Session: Pancreatic cancer: Where are we now and where are we going?
Resources:
Slides
Webcast
Can we be more precise in peri-operative therapy?
Presenter: Michel Ducreux
Session: Pancreatic cancer: Where are we now and where are we going?
Resources:
Slides
Webcast
Locally advanced disease: Drugs alone or with the addition of radiotherapy?
Presenter: Stefano Cascinu
Session: Pancreatic cancer: Where are we now and where are we going?
Resources:
Slides
Webcast
New targets on the horizon: Integrating genomics with tumour microenvironment
Presenter: Eileen O'Reilly
Session: Pancreatic cancer: Where are we now and where are we going?
Resources:
Slides
Webcast
Introduction: Why differentiation matters
Presenter: Suzanne George
Session: The even rarer sarcomas: Treating the untreatable
Resources:
Slides
Webcast
The pathologist's point of view: Methodology to make a difference
Presenter: Hans-Ulrich Schildhaus
Session: The even rarer sarcomas: Treating the untreatable
Resources:
Slides
Webcast